BlackRock Fund Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

BlackRock Fund Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.85M	Sell	411,554 -181,823	-31%	-$1.64M	﹤0.01%	3013
2016 Q3	$5.8M	Buy	593,377 +37,390	+7%	+$504K	﹤0.01%	2778
2016 Q2	$7.86M	Buy	555,987 +93,015	+20%	+$1.45M	﹤0.01%	2545
2016 Q1	$6.47M	Buy	462,972 +16,541	+4%	+$243K	﹤0.01%	2603
2015 Q4	$9.11M	Buy	446,431 +219,502	+97%	+$3.39M	﹤0.01%	2499
2015 Q3	$2.98M	Sell	226,929 -2,940	-1%	-$48.8K	﹤0.01%	3024
2015 Q2	$3.53M	Buy	229,869 +66,147	+40%	+$1.27M	﹤0.01%	3057
2015 Q1	$3.27M	Buy	163,722 +7,818	+5%	+$175K	﹤0.01%	3014
2014 Q4	$3.28M	Buy	155,904 +23,262	+18%	+$474K	﹤0.01%	3049
2014 Q3	$2.47M	Buy	132,642 +13,297	+11%	+$241K	﹤0.01%	3086
2014 Q2	$2.76M	Buy	+119,345	New	+$2.1M	﹤0.01%	3080

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BlackRock Fund Advisors's AGTC Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Applied Genetic Technologies Corporation (AGTC) stake by 31% in Q4 2016, selling an estimated $1.64M and leaving 411,554 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3013.

BlackRock Fund Advisors first reported a position in AGTC in Q2 2014 and has held it in 11 quarters since. The position peaked at $9.11M in Q4 2015. 90 funds tracked by Wall St. Rank hold AGTC as of Q4 2016.

BlackRock Fund Advisors held 411,554 shares of Applied Genetic Technologies Corporation worth $3.85M as of Q4 2016.
BlackRock Fund Advisors sold 181,823 Applied Genetic Technologies Corporation shares in Q4 2016, an estimated $1.64M.
Applied Genetic Technologies Corporation made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3013 holding.
BlackRock Fund Advisors first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and has held it in 11 quarters since.
BlackRock Fund Advisors's Applied Genetic Technologies Corporation position peaked at $9.11M in Q4 2015.
90 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.